Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel W Lin

Showing results (161-170 of 287) with videos related to

Pageof 29
Sort By:
The Journal of Clinical Endocrinology and Metabolism|March 28, 2013
Response of the insulin-like growth factor (IGF) system to IGF-IR inhibition and androgen deprivation in a neoadjuvant prostate cancer trial: effects of obesity and androgen deprivationJames P Dean, Cynthia C Sprenger, Junxiang Wan, et al.
Cancer|February 14, 2024
The Prostate Cancer Active Lifestyle Study (PALS): A randomized controlled trial of diet and exercise in overweight and obese men on active surveillanceJonathan L Wright, Jeannette M Schenk, Roman Gulati, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 22, 2013
Urinary TMPRSS2:ERG and PCA3 in an active surveillance cohort: results from a baseline analysis in the Canary Prostate Active Surveillance StudyDaniel W Lin, Lisa F Newcomb, Elissa C Brown, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 18, 2011
Genetic variants in the LEPR, CRY1, RNASEL, IL4, and ARVCF genes are prognostic markers of prostate cancer-specific mortalityDaniel W Lin, Liesel M FitzGerald, Rong Fu, et al.
Prostate Cancer and Prostatic Diseases|August 30, 2019
The development and comparative effectiveness of a patient-centered prostate biopsy report: a prospective, randomized studyJasmir G Nayak, Nicholas Scalzo, Alice Chu, et al.
The Prostate|August 12, 2020
Optimizing the management of castration-resistant prostate cancer patients: A practical guide for cliniciansNeal D Shore, Charles G Drake, Daniel W Lin, et al.
BJU International|June 10, 2026
The 'Prostate Cancer Screening for People at Genetic Risk of Aggressive Disease' (PATROL) studyHeather H Cheng, Kara N Maxwell, Keyan Salari, et al.
Cancer Research|May 19, 2007
Intraprostatic androgens and androgen-regulated gene expression persist after testosterone suppression: therapeutic implications for castration-resistant prostate cancerElahe A Mostaghel, Stephanie T Page, Daniel W Lin, et al.
European Urology|July 19, 2017
A Systematic Review and Framework for the Use of Hormone Therapy with Salvage Radiation Therapy for Recurrent Prostate CancerDaniel E Spratt, Robert T Dess, Zachary S Zumsteg, et al.
The Journal of Urology|November 5, 2016
Timing of Adverse Prostate Cancer Reclassification on First Surveillance Biopsy: Results from the Canary Prostate Cancer Active Surveillance StudyLiam C Macleod, William J Ellis, Lisa F Newcomb, et al.
Pageof 29

Showing results (161-170 of 287) with videos related to

Sort By:
Pageof 29
The Journal of Clinical Endocrinology and Metabolism|March 28, 2013
Response of the insulin-like growth factor (IGF) system to IGF-IR inhibition and androgen deprivation in a neoadjuvant prostate cancer trial: effects of obesity and androgen deprivationJames P Dean, Cynthia C Sprenger, Junxiang Wan, et al.
Cancer|February 14, 2024
The Prostate Cancer Active Lifestyle Study (PALS): A randomized controlled trial of diet and exercise in overweight and obese men on active surveillanceJonathan L Wright, Jeannette M Schenk, Roman Gulati, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 22, 2013
Urinary TMPRSS2:ERG and PCA3 in an active surveillance cohort: results from a baseline analysis in the Canary Prostate Active Surveillance StudyDaniel W Lin, Lisa F Newcomb, Elissa C Brown, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 18, 2011
Genetic variants in the LEPR, CRY1, RNASEL, IL4, and ARVCF genes are prognostic markers of prostate cancer-specific mortalityDaniel W Lin, Liesel M FitzGerald, Rong Fu, et al.
Prostate Cancer and Prostatic Diseases|August 30, 2019
The development and comparative effectiveness of a patient-centered prostate biopsy report: a prospective, randomized studyJasmir G Nayak, Nicholas Scalzo, Alice Chu, et al.
The Prostate|August 12, 2020
Optimizing the management of castration-resistant prostate cancer patients: A practical guide for cliniciansNeal D Shore, Charles G Drake, Daniel W Lin, et al.
BJU International|June 10, 2026
The 'Prostate Cancer Screening for People at Genetic Risk of Aggressive Disease' (PATROL) studyHeather H Cheng, Kara N Maxwell, Keyan Salari, et al.
Cancer Research|May 19, 2007
Intraprostatic androgens and androgen-regulated gene expression persist after testosterone suppression: therapeutic implications for castration-resistant prostate cancerElahe A Mostaghel, Stephanie T Page, Daniel W Lin, et al.
European Urology|July 19, 2017
A Systematic Review and Framework for the Use of Hormone Therapy with Salvage Radiation Therapy for Recurrent Prostate CancerDaniel E Spratt, Robert T Dess, Zachary S Zumsteg, et al.
The Journal of Urology|November 5, 2016
Timing of Adverse Prostate Cancer Reclassification on First Surveillance Biopsy: Results from the Canary Prostate Cancer Active Surveillance StudyLiam C Macleod, William J Ellis, Lisa F Newcomb, et al.
Pageof 29